Cited in:


This article has been cited by:

  1. 1
    Florence Enjalbert, David E. Krysztof, Daniel Candotti, Jean-Pierre Allain, Susan L. Stramer, Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors, Transfusion, 2014, 54, 4
  2. 2
    K. T. Lin, C. L. Chang, M. H. Tsai, K. S. Lin, J. Saldanha, C. M. Hung, Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test, Vox Sanguinis, 2014, 106, 2
  3. 3
    Philip Kiely, Angelo R. Margaritis, Clive R. Seed, Hung Yang, Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection, Transfusion, 2014, 54, 4
  4. 4
    C. R. Seed, P. Kiely, A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening, Vox Sanguinis, 2013, 105, 4
  5. 5
    Marion Vermeulen, Charl Coleman, Josephine Mitchel, Ravi Reddy, Harry Drimmelen, Tracy Ficket, Nico Lelie, Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections, Transfusion, 2013, 53, 10pt2
  6. 6
    L. Viet, A. Husebekk, H. Husum, E. Skjerve, Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam, Transfusion Medicine, 2013, 23, 6